基于发作模式和疾病严重程度对特应性皮炎患者的特征分析:一项丹麦人群研究
该研究纳入丹麦皮肤队列中1557例活动性特应性皮炎(AD)患者,按过去12个月发作次数分为0次、1-5次、6-10次和>10次四组。结果显示发作次数越多,PO-SCORAD严重度评分和DLQI生活质量受损程度越高;但仍有相当比例频繁发作患者对当前治疗满意。结论提示发作信息有助于优化治疗决策,减少轻度但频繁发作患者的治疗不足。
要点
- 发作次数越多,AD严重度(PO-SCORAD)和生活质量受损(DLQI)越高。
- 即使>10次发作的患者中仍有23.7%对当前治疗极度或非常满意。
- 采集发作模式信息可辅助治疗决策,避免轻度但频繁发作患者治疗不足。
核心结论
- 发作频繁的AD患者往往报告更高的疾病严重度和生活质量受损。
- 发作信息可裨益治疗决策,从而减少轻度AD但严重发作患者的治疗不足。
研究设计与样本
- 基于丹麦皮肤队列的人群研究,纳入1557例有活动性AD且具备过去12个月发作次数数据的患者。
- 分类变量以频率和百分比呈现,数值变量以中位数和四分位距(IQR)呈现,组间差异采用卡方检验。
主要发现
- 过去12个月发作次数分布:0次57例,1-5次698例,6-10次324例,>10次478例。
- 四组发作 strata 的PO-SCORAD中位数(IQR)分别为13.0(5.6-22.3)、29.7(20.8-40.6)、36.3(26.7-47.6)、42.9(30.7-55.6)。
- 四组发作 strata 的DLQI中位数(IQR)分别为1.0(0.0-2.0)、3.0(1.0-7.0)、4.0(1.8-9.0)、7.0(3.0-11.0)。
- 无发作患者对当前治疗的满意度总体更高;1-5次、6-10次和>10次发作患者中分别有36.8%、24.6%和23.7%报告极度或非常满意。
关键数值与推荐
- 发作分层依据过去12个月发作次数:0次、1-5次、6-10次、>10次。
- 疾病严重度采用PO-SCORAD评估,生活质量采用DLQI评估。
临床怎么用
- 临床评估AD时应常规询问过去12个月的发作次数,以识别轻度但频繁发作的患者。
- 对频繁发作但静态严重度评分不高的患者,应考虑升级治疗以避免治疗不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Flare patterns are not routinely considered in the severity classification or in clinical decision-making of atopic dermatitis (AD), but frequent or severe flares may contribute considerably to the disease burden. OBJECTIVES: To characterize patients with AD in relation to their flare pattern and compare flare patterns to disease severity, life quality and treatment satisfaction. METHODS: Patients with AD from the Danish Skin Cohort were included if they had active AD with and available data on number of flare-ups within the last 12 months. Categorical variables were presented as frequencies and percentages, whereas numerical variables were presented as median and interquartile ranges (IQR). Between-group differences were tested with chi-squared tests. RESULTS: A total of 1557 patients were included, with 57 reporting 0 flares, 698 (1-5 flares), 324 (6-10 flares) and 478 reporting >10 flares during the past 12 months. Both the severity measured by PO-SCORAD and the impairment of life quality measured by DLQI were higher among patients with more flares (median [IQR] PO-SCORAD: 13.0 [5.6-22.3], 29.7 [20.8-40.6], 36.3 [26.7-47.6]and 42.9 [30.7-55.6], respectively for the four flares strata, and median [IQR] DLQI: 1.0 [0.0-2.0], 3.0 [1.0-7.0], 4.0 [1.8-9.0] and 7.0 [3.0-11.0]). Satisfaction with the current treatment was generally higher among patients with no flares. However, 36.8%, 24.6% and 23.7% of patients with 1-5, 6-10 and >10 flares reported being extremely or very satisfied with their current treatment. CONCLUSIONS: Patients with many flares often report a higher severity and impairment of life quality compared to patients with fewer flares. Information on flaring could benefit treatment decisions, thereby decreasing undertreatment of patients with mild AD but severe flaring.
引用
- Nielsen ML, Nymand LK, Domenech Pena A, et al. Characterization of patients with atopic dermatitis based on flare patterns and severity of disease: A Danish population-based study. J Eur Acad Dermatol Venereol. 2024. PMID: 38813970. doi:10.1111/jdv.20160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。